Quarterly report pursuant to Section 13 or 15(d)

Income (Loss) Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details)

v3.24.3
Income (Loss) Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net loss available to stockholders $ (930,408) $ (481,573) $ (3,574,171) $ (2,751,711)
Weighted average shares outstanding - basic 24,850,261 24,850,261 24,850,261 24,850,261
Effect of dilutive securities:        
Weighted average shares outstanding - Diluted 24,850,261 24,850,261 24,850,261 24,850,261
Net income (loss) per share - basic (in USD per share) $ (0.04) $ (0.02) $ (0.14) $ (0.11)
Net income (loss) per share - diluted (in usd per share) $ (0.04) $ (0.02) $ (0.14) $ (0.11)
Stock Options        
Effect of dilutive securities:        
Stock options 0 0 0 0
Anti-dilutive shares underlying stock options outstanding 1,726,086 1,829,051 1,726,086 1,829,051